Results 41 to 50 of about 206,766 (202)

Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial. [PDF]

open access: yes, 2014
BACKGROUND: Novel tuberculosis vaccines should be safe, immunogenic, and effective in various population groups, including HIV-infected individuals. In this phase II multi-centre, double-blind, placebo-controlled trial, the safety and immunogenicity of ...
Said, Khadija   +67 more
core   +1 more source

Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic

open access: yesnpj Vaccines
A recommendation from healthcare personnel (HCP) is a strong predictor of vaccination. This study aimed to measure how HCP vaccine attitudes and recommendations changed during the COVID-19 pandemic. HCP were surveyed in January 2023 using a double opt-in
Matthew Z. Dudley   +4 more
doaj   +1 more source

Active Vaccine Safety Surveillance: Global Trends and Challenges in China

open access: yesHealth Data Science, 2021
Importance. The great success in vaccine-preventable diseases has been accompanied by vaccine safety concerns. This has caused vaccine hesitancy to be the top 10 in threats to global health.
Zhike Liu   +8 more
doaj   +1 more source

A narrative review of considerations when assessing potential relationships between Guillain-Barré syndrome and vaccines

open access: yesHuman Vaccines & Immunotherapeutics
Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyradiculoneuropathy that can result in progressive muscle weakness, paralysis, and, in severe cases, respiratory failure.
Sarah Elizabeth Williams   +9 more
doaj   +1 more source

Evaluation of the safety profile of COVID-19 vaccines: a rapid review

open access: yesBMC Medicine, 2021
Background The rapid process of research and development and lack of follow-up time post-vaccination aroused great public concern about the safety profile of COVID-19 vaccine candidates. To provide comprehensive overview of the safety profile of COVID-19
Qianhui Wu   +7 more
doaj   +1 more source

The vaccine safety belt

open access: yesCleveland Clinic Journal of Medicine, 2015
Arguments against vaccination have acquired a libertarian tone, like the argument against compulsory wearing of seat belts.
openaire   +2 more sources

Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. [PDF]

open access: yes, 2010
BACKGROUND: Phase III trials of the malaria vaccine, RTS, S, are now underway across multiple sites of varying transmission intensity in Africa. Heterogeneity in exposure, vaccine response and waning of efficacy may bias estimates of vaccine efficacy ...
Michael T White   +11 more
core   +1 more source

High Frequency of COVID-19 Vaccine Hesitancy among Canadians Immunized for Influenza: A Cross-Sectional Survey

open access: yesVaccines, 2022
We assessed the frequency and correlates of COVID-19 vaccine hesitancy before Canada’s vaccine rollout. A cross-sectional vaccine hesitancy survey was completed by consecutive patients/family members/staff who received the influenza vaccine at McGill ...
Valeria Valerio   +10 more
doaj   +1 more source

The use of a computerized database to monitor vaccine safety in Viet Nam. [PDF]

open access: yes, 2005
Health information systems to monitor vaccine safety are used in industrialized countries to detect adverse medical events related to vaccinations or to prove the safety of vaccines. There are no such information systems in the developing world, but they
Ali, Mohammad   +9 more
core  

Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination

open access: yesInfectious Diseases and Therapy
Introduction Rare myocarditis and pericarditis cases have occurred in coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccine recipients. Troponin levels, a potential marker of myocardial injury, were assessed in healthy participants before and ...
Timothy E. Albertson   +25 more
doaj   +1 more source

Home - About - Disclaimer - Privacy